PBPK for Drug-Drug Interactions: Why It Matters
If you are in drug development, there is one [...]
ESQlabs Brings Next-Generation Risk Assessment to the United States
ESQlabs, a European leader in physiologically based kinetic (PBPK) modeling, and [...]
Our latest Face to Face was once again, a meeting to remeber
This time, we gathered in Athens: a city rich [...]
We are ready for PAGE 26… are you?
At the upcoming PAGE - Population Approach Group Europe [...]
ESQlabs as Gold Sponsor at QSP Conference 26
After four years, the Quantitative Systems Pharmacology Conference is [...]
